[dewolf]

Originally Posted by tabs

Yes Lad start hitting the Testo.....but be aware that it is the Testo that turns on Men as they age and causes Prostate Cancer...That is why the older you get the more chance you got it. Maybe that is natures way of thining the old bulls out the herd for the new young bucks..

Or as Pete Townsend once said ...."The old men got all the money."

That it causes cnacer in everything I have read says no. And if your using testo for muscle growth and not a controlled replacement therapy then you are going to have problems.



Appropriate use of testosterone can prevent or reduce the likelihood of osteoporosis, type 2 diabetes, cardio-vascular disease (CVD), obesity, depression and anxiety and the risk of early mortality.(7) Health benefits include positive effects on mood, energy levels, verbal fluency, strength, increased muscle size, decreased body fat and increased bone density.(2-27) Testosterone restores and enhances male libido, and is a treatment for male sexual dysfunction.(33)

The 2007 EPIC study concluded that testosterone level is inversely related to cardiovascular disease risk and all-cause mortality. Thus, low testosterone may be a marker for increased risk of cardiovascular disease.(35)

Low Testosterone levels is also linked to reduced cognitive performance and onset of Alzheimers in elderly men.
Harvard researchers have clearly shown that testosterone therapy does not increase the risk of prostate cancer. A team of researchers, led by Dr. Abraham Morgentaler, came to the conclusion that the medical establishment was wrong in suggesting that testosterone replacement therapy increases the risk of prostate cancer.

As a matter of fact, what the researchers actually found might surprise you. Dr. Morgentaler’s team meticulously showed that low testosterone actually increased the risk of prostate cancer. Go figure.

In one of their studies,1 they compared the results of testosterone therapy given for 12 months in two groups of men with low testosterone. The first group consisted of 20 men considered to be at high risk for prostate cancer based on biopsy results showing an allegedly precancerous condition called prostatic intraepithelial neoplasia (PIN).

The second group consisted of 55 men with normal biopsy results. At the end of one year of treatment, both groups had a similar, modest increase in PSA. One man in the study, who was in the high-risk group, developed cancer.

So, overall testosterone therapy resulted in a one-year cancer rate of 1.3% (one of 75 men). More importantly, the one-year cancer rate among the high-risk men with PIN was 5%. Keep in mind that the known cancer rate of men at high risk for developing cancer is 25% over three years. As you can see, testosterone therapy did not increase the risk of prostate cancer in anyone, including the men that were at high risk.